A blood test that measures a single protein in the bloodstream is reshaping how doctors think about Alzheimer’s disease, ...

PrecivityAD2 is the first blood-based biomarker for people as young as 40 with cognitive s ...

The tools for catching Alzheimer’s early on just got even sharper.

There is no cure for dementia, and as the condition progresses, the patient may not be able to recognize loved ones.

C2N’s Alzheimer’s test is the first to be FDA-cleared for use in patients as young as 40 who present with cognitive ...

The U.S. Food & Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2® test, providing patients and health care ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 50 GP surgeries across central and northern Scotland are participating in the initiative, known as Bringing Alzheimer's ...

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology ...

An experimental blood test can spot signs of Alzheimer’s disease earlier. It can also determine when patients may develop symptoms. Doctors say that more research is needed. While it’s a life-altering ...

The tests aren’t a guarantee that someone will develop dementia, but that hasn’t stopped people from getting them.

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Songpa-gu is the only district in Seoul offering a free blood test that can predict a person's risk of developing Alzheimer's ...